Autor: "Chandhok NS" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: What constitutes meaningful improvement in myelodysplastic syndromes?
Autorzy:: Chandhok NS; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2022 Nov; Vol. 63 (11), pp. 2528-2535. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji:: Journal Article
MeSH Terms:: Myelodysplastic Syndromes*/therapy
Myelodysplastic Syndromes*/drug therapy
Leukemia, Myeloid, Acute*
Thrombocytopenia*
Anemia*
Humans ; Quality of Life ; Hematopoiesis

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Hypomethylating agent based combinations in higher risk myelodysplastic syndrome.
Autorzy:: Chandhok NS; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
Lewis R; Smilow Cancer Center at Yale New Haven Hospital, New Haven, CT, USA.
Prebet T; Smilow Cancer Center at Yale New Haven Hospital, New Haven, CT, USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2020 May; Vol. 61 (5), pp. 1012-1027. Date of Electronic Publication: 2019 Dec 09.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Antimetabolites, Antineoplastic*/adverse effects
Myelodysplastic Syndromes*/drug therapy
Myelodysplastic Syndromes*/genetics
Azacitidine/therapeutic use ; DNA Methylation ; Humans

Czasopismo naukowe

Informacja